How well can an intracranial bleed or hematoma be visualized on a computed tomography (CT) head scan with versus without contrast?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Non-Contrast CT is Superior to Contrast-Enhanced CT for Visualizing Intracranial Hemorrhage

Non-contrast head CT is the gold standard and first-line imaging test for detecting acute intracranial hemorrhage, while contrast-enhanced CT may actually obscure subtle hemorrhages and is not recommended as the initial imaging study. 1

Imaging Characteristics and Detection Capabilities

Non-Contrast CT

  • Highly sensitive for acute hemorrhage detection
  • Rapid acquisition time (critical in emergency situations)
  • Effectively identifies location, size, and mass effect of hemorrhages
  • Acute hemorrhages appear hyperdense (50-100 Hounsfield units)
  • Recommended by the American College of Radiology (ACR) and American Heart Association/American Stroke Association 1

Contrast-Enhanced CT

  • Not recommended as first-line imaging for acute intracranial hemorrhage
  • May obscure subtle hemorrhages due to contrast enhancement
  • Should only be used after hemorrhage has been identified on non-contrast CT
  • Primarily indicated to evaluate underlying structural lesions (e.g., suspected metastatic disease) when MRI is not feasible 1

Clinical Decision Algorithm

  1. Initial Presentation: Patient with suspected intracranial hemorrhage

    • First imaging study: Non-contrast head CT
    • Rationale: Highest sensitivity for acute hemorrhage without risk of obscuring blood
  2. If hemorrhage identified on non-contrast CT:

    • Consider CT angiography (CTA) if vascular abnormality suspected
    • CTA has >90% sensitivity and specificity compared to catheter arteriography 1
    • "CTA spot sign" may help predict hematoma expansion
  3. If additional information needed after hemorrhage identification:

    • Consider contrast-enhanced CT to evaluate underlying structural lesions
    • Consider MRI with gradient echo (GRE) or T2* susceptibility-weighted imaging for better characterization
  4. If non-contrast CT negative but clinical suspicion remains high:

    • Proceed to MRI with GRE or T2* susceptibility-weighted imaging
    • MRI is more sensitive for small bleeds, particularly in posterior fossa or brainstem 1

Important Pitfalls to Avoid

  • Critical Error: Administering contrast before initial non-contrast CT can obscure hemorrhage and lead to missed diagnosis 1
  • Small hemorrhages, especially in the posterior fossa, may be missed on non-contrast CT and require MRI for detection 1
  • Other pathologic processes can mimic hemorrhage on CT (calcifications, vascular malformations, highly cellular tumors) 2
  • Dual-energy CT can help separate hemorrhage from other causes of hyperattenuation, but has limited availability 2

Special Considerations

  • For subacute and chronic hemorrhages, MRI is more sensitive than CT 1
  • When cerebral venous thrombosis is suspected as a cause of hemorrhage, CT venography (CTV) or MR venography (MRV) is indicated 1
  • Patients with thicker acute subdural hematomas, lower hemoglobin levels, and higher leukocyte counts require closer observation due to higher risk of requiring delayed surgical intervention 1

References

Guideline

Imaging Guidelines for Intracranial Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pitfalls in the Imaging Interpretation of Intracranial Hemorrhage.

Seminars in ultrasound, CT, and MR, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.